NCT02805322

Brief Summary

Quantify the reliability and agreement of estimated core body temperature using the InstaTemp MD™ and other widely marketed reference Thermometers

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
138

participants targeted

Target at P75+ for phase_4 healthy

Timeline
Completed

Started Apr 2016

Shorter than P25 for phase_4 healthy

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2016

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2016

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2016

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

June 9, 2016

Completed
11 days until next milestone

First Posted

Study publicly available on registry

June 20, 2016

Completed
Last Updated

June 20, 2016

Status Verified

June 1, 2016

Enrollment Period

2 months

First QC Date

June 9, 2016

Last Update Submit

June 15, 2016

Conditions

Outcome Measures

Primary Outcomes (2)

  • Mean Bias

    Mean Bias (95% Levels of agreement) between ARC InstaTemp™ MD Non-Contact InfraRed Thermometry Device and (a) the Covidien Tympanic thermometer and (b) the Welch Allyn thermometer at an oral or axillary site as appropriate to subjects' age and clinical circumstance.

    Baseline temperature measurement using all relevant interventions

  • Reproducibility

    Overall reproducibility of ARC InstaTemp™ MD Non-Contact InfraRed Thermometry Device.

    Baseline measurement of 3 temperature reading

Study Arms (2)

Temporal Temperature Measurement

EXPERIMENTAL

Infrared Temporal Temperature Measurement using the ARC InstaTemp MD in three different age groups with a specified percentage reporting as febrile.

Device: ARC InstaTemp MD

Tympanic and/or Sublingual Temperature

ACTIVE COMPARATOR

Tympanic and/or Sublingual Temperature Measurement using one or both of two widely used reference clinical thermometers in three different age groups with a specified percentage reporting as febrile. Choice between Tympanic and/or Sublingual is determined based on standard of care in study site Reference Thermometer 1 - Covidien Genius 2 Tympanic Thermometer Reference Thermometer 2 - Welch Allen SureTemp Plus Sublingual Thermometer

Device: Covidien Genius 2 Tympanic ThermometerDevice: Welch Allen SureTemp Plus Sublingual Thermometer

Interventions

Measurement of Body Temperature using an Infrared Non-Touch Thermometer - Experimental arm.

Temporal Temperature Measurement

Measurement of Tympanic Temperature using a standard approved method - Control arm.

Tympanic and/or Sublingual Temperature

Measurement of Sublingual Temperature using a standard approved method - Control arm.

Tympanic and/or Sublingual Temperature

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Any age
  • Either gender
  • Attending ED, outpatients or inpatient Departments of Cork University Hospital Campus
  • Provision of informed consent or in case of minor's provision of age appropriate assent with informed consent of parent (legal guardian).

You may not qualify if:

  • Those who in the opinion of the researcher are too agitated, distressed or who are otherwise unable to cooperate with study procedures
  • Those who forehead cannot be fully exposed to the ambient conditions for at least 15 minutes
  • Those with signs or recent history of inflammation or infection of the forehead or at the Reference Clinical Test site
  • Subjects currently using cooling blankets or fans.
  • Subjects currently receiving treatment with thyroxine, barbiturates, antipsychotics, corticosteroids, alcoholic intoxication, documented illicit drug use or immunizations In the previous 5 days
  • Any recent hot or cold drinks prior to a sub-lingual reading (i.e. 15min before measurement)
  • Those participating in a clinical trial of an investigational medicinal product

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cork University Hospital

Cork, Munster, Ireland

Location

MeSH Terms

Conditions

Fever

Condition Hierarchy (Ancestors)

Body Temperature ChangesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Joe Eustace, Prof

    Cork University Hospital, Ireland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 4
Allocation
NON RANDOMIZED
Masking
NONE
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 9, 2016

First Posted

June 20, 2016

Study Start

April 1, 2016

Primary Completion

June 1, 2016

Study Completion

June 1, 2016

Last Updated

June 20, 2016

Record last verified: 2016-06

Data Sharing

IPD Sharing
Will not share

Locations